Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |